Acer Therapeutics Inc. Quarterly Weighted Average Number of Shares Outstanding, Diluted from Q2 2021 to Q3 2023

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Acer Therapeutics Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q2 2021 to Q3 2023.
  • Acer Therapeutics Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2023 was 24.5M shares, a 52.1% increase year-over-year.
  • Acer Therapeutics Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 15.8M shares, a 10.5% increase from 2021.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2023 24.5M +8.37M +52.1% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-20
Q2 2023 24.5M +6.78M +38.4% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-14
Q1 2023 21.1M +6.8M +47.5% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-15
Q4 2022 15.8M Oct 1, 2022 Dec 31, 2022 10-K 2023-03-27
Q3 2022 16.1M +1.78M +12.4% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-20
Q2 2022 17.7M +3.37M +23.6% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 14.3M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q3 2021 14.3M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 14.3M Apr 1, 2021 Jun 30, 2021 10-Q/A 2022-11-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.